Cargando…
Editorial: Kappa opioid receptors revealed: Disentangling the pharmacology to open up new therapeutic strategies
Autores principales: | Walwyn, Wendy Margaret, Valenza, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413185/ https://www.ncbi.nlm.nih.gov/pubmed/36034837 http://dx.doi.org/10.3389/fphar.2022.973780 |
Ejemplares similares
-
Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands
por: Sturaro, Chiara, et al.
Publicado: (2022) -
Editorial: Opioids in the time of the COVID-19 pandemic: from cellular mechanisms to public health policy
por: John, Scott, et al.
Publicado: (2023) -
The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies
por: Dalefield, Martin L., et al.
Publicado: (2022) -
Editorial: The Challenge Posed by New Synthetic Opioids: Pharmacology and Toxicology
por: Pichini, Simona, et al.
Publicado: (2019) -
Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders
por: Butelman, Eduardo R., et al.
Publicado: (2015)